Universidad CEU San Pablo
Gonzalo Herradón obtained his PhD in pharmacology at the Faculty of Pharmacy of the University CEU San Pablo (2003). In 2002, Dr. Herradón joined as Research Investigator the neurobiology department at Millennium Pharmaceuticals, Inc (Cambridge, MA, USA) to work in new strategies to identify novel genes involved in the development and maintenance of neuropathic pain. In 2003, he started a 3-year postdoctoral stay in the lab of Dr. Thomas F. Deuel at The Scripps Research Institute (La Jolla, CA, USA).
In 2006, Dr. Herradón returned to the Faculty of Pharmacy at the University CEU San Pablo in Madrid (Spain). In 2007, he became the coordinator of the bilingual program of Pharmacy CEU-University of Chicago and Assistant Professor of Pharmacology. He is also a Faculty Member of the m+vision program, an innovative project in biomedical imaging developed in collaboration between the government of Madrid and Massachusetts Institute of Technology (MIT). In 2011 Dr. Herradón received the Award from the Royal National Academy of Pharmacy of Spain to the best research work in opioids and pain transmission and became Associate Professor of Pharmacology.
During the last decade his group has been dedicated to dissect the possible roles of midkine and pleiotrophin in drug addiction, becoming lately more focused on the involvement of the signalling pathways of both cytokines in alcohol abuse and neuroinflammation.